Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization

被引：0

作者：

Anna C. F. Lewis

Emma F. Perez

Anya E. R. Prince

Hana R. Flaxman

Lizbeth Gomez

Deanna G. Brockman

Paulette D. Chandler

Benjamin J. Kerman

Matthew S. Lebo

Jordan W. Smoller

Scott T. Weiss

Carrie L. Blout Zawatksy

James B. Meigs

Robert C. Green

Jason L. Vassy

Elizabeth W. Karlson

机构：

[1] Harvard University,E.J. Safra Center for Ethics

[2] Brigham and Women’s Hospital,Department of Medicine

[3] Mass General Brigham Personalized Medicine,College of Law

[4] University of Iowa,Department of Pathology

[5] Weill Cornell Medical College,undefined

[6] Color Health,undefined

[7] Brigham and Women’s Hospital,undefined

[8] Harvard Medical School,undefined

[9] Program in Medical and Population Genetics,undefined

[10] Broad Institute of MIT and Harvard,undefined

[11] Center for Genomic Medicine,undefined

[12] Massachusetts General Hospital,undefined

[13] Center for Precision Psychiatry,undefined

[14] Massachusetts General Hospital,undefined

[15] Stanley Center for Psychiatric Research,undefined

[16] Broad Institute of MIT and Harvard,undefined

[17] Channing Division of Network Medicine,undefined

[18] Population Precision Health,undefined

[19] Ariadne Labs,undefined

[20] The MGH Institute of Health Professions,undefined

[21] Division of General Internal Medicine,undefined

[22] Massachusetts General Hospital,undefined

[23] Mass General Brigham Personalized Medicine,undefined

[24] Veterans Affairs Boston Healthcare System,undefined

[25] Division of General Internal Medicine and Primary Care,undefined

[26] Brigham and Women’s Hospital,undefined

来源：

Genome Medicine | / 14卷

关键词：

Polygenic risk scores; Report design; Preventative medicine; Personalized medicine; Qualitative semi-structured interviews;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

共 50 条

[31] Future implications of polygenic risk scores for life insurance underwriting
Tatiane Yanes
Jane Tiller
Casey M. Haining
Courtney Wallingford
Margaret Otlowski
Louise Keogh
Aideen McInerney-Leo
Paul Lacaze
npj Genomic Medicine, 9
[32] Future implications of polygenic risk scores for life insurance underwriting
Yanes, Tatiane
Tiller, Jane
Haining, Casey M.
Wallingford, Courtney
Otlowski, Margaret
Keogh, Louise
McInerney-Leo, Aideen
Lacaze, Paul
NPJ GENOMIC MEDICINE, 2024, 9 (01)
[33] Perspectives of diverse Spanish- and English-speaking patients on the clinical use of polygenic risk scores
Suckiel, Sabrina A.
Braganza, Giovanna T.
Aguiniga, Karla Lopez
Odgis, Jacqueline A.
Bonini, Katherine E.
Kenny, Eimear E.
Hamilton, Jada G.
Abul-Husn, Noura S.
GENETICS IN MEDICINE, 2022, 24 (06) : 1217 - 1226
[34] The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives
Cupido, Arjen J.
Tromp, Tycho R.
Hovingh, G. Kees
CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (02) : 112 - 116
[35] Polygenic risk scores: from research tools to clinical instruments
Lewis, Cathryn M.
Vassos, Evangelos
GENOME MEDICINE, 2020, 12 (01)
[36] The clinical utility of polygenic risk scores for chronic lymphocytic leukemia
Sud, Amit
Law, Philip J.
Houlston, Richard S.
LEUKEMIA, 2021, 35 (12) : 3608 - 3610
[37] The clinical utility of polygenic risk scores for chronic lymphocytic leukemia
Amit Sud
Philip J. Law
Richard S. Houlston
Leukemia, 2021, 35 : 3608 - 3610
[38] Clinical utility of polygenic risk scores for predicting NAFLD disorders
Dessein, Alain
JOURNAL OF HEPATOLOGY, 2021, 74 (04) : 769 - 770
[39] Clinical utility of polygenic risk scores for coronary artery disease
Derek Klarin
Pradeep Natarajan
Nature Reviews Cardiology, 2022, 19 : 291 - 301
[40] Clinical utility of polygenic risk scores: a critical 2023 appraisal
Koch, Sebastian
Schmidtke, Joerg
Krawczak, Michael
Caliebe, Amke
JOURNAL OF COMMUNITY GENETICS, 2023, 14 (05) : 471 - 487

← 1 2 3 4 5 →